Carlyle invests more than $250m in Pharmapacks

The Carlyle Group has invested more than $250 million in Pharmapacks, a ecommerce enablement platform and retail seller for brands across major ecommerce marketplaces.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this